This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by McNAMEE, P.
Right arrow Articles by BUCK, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNAMEE, P.
Right arrow Articles by BUCK, D.
The British Journal of Psychiatry (2001) 179: 261-266
© 2001 The Royal College of Psychiatrists

Costs of dementia in England and Wales in the 21st century

PAUL McNAMEE, MSc

Department of Epidemiology & Public Health, School of Health Sciences, University of Newcastle

JOHN BOND, BA, DEBBIE BUCK, BA and the Resource Implications Study of the Medical Research Council Cognitive Function and Ageing Study

Centre for Health Services Research, School of Health Sciences, University of Newcastle, Newcastle-upon-Tyne, UK

Correspondence: P. McNamee, Department of Epidemiology & Public Health, School of Health Sciences, 21 Claremont Place, University of Newcastle, Newcastle-upon-Tyne NE2 4AA, UK

Declaration of interest None. Funding described in Acknowledgements.

Background An important factor determining future health care expenditure is the relationship between ageing, health status and development of age-related disorders such as dementia.

Aims To estimate the formal care costs associated with dementia in England and Wales between 1994 and 2031.

Method Epidemiological cost model, applied to individuals aged 65 years or over with dementia, using estimates of life expectancy with dementia and dementia-free life expectancy.

Results Total costs per year were £0.95 billion (men) and £5.35 billion (women) using 1994 population estimates. For 2031, costs were £2.34 billion and £11.20 billion, respectively. Reduced dementia prevalence rates and improvements in mental and physical functioning resulted in lower estimates: £1.01 billion (men) and £5.77 billion (women), and £1.65 billion (men) and £7.87 billion (women), respectively.

Conclusions Future increases in the population aged 65 years or over lead to rising formal care costs. However, the magnitude of cost changes depends on assumptions over dementia prevalence and levels of mental and physical functioning.




This article has been cited by other articles:


Home page
 Age AgeingHome page
C. Jagger, R. Matthews, J. Lindesay, T. Robinson, P. Croft, and C. Brayne
The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS)
Age Ageing, May 1, 2009; 38(3): 319 - 325.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. McGurn, I. J. Deary, and J. M. Starr
Childhood cognitive ability and risk of late-onset Alzheimer and vascular dementia
Neurology, September 30, 2008; 71(14): 1051 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
C. Brayne, C. McCracken, and F. E Matthews
Cohort Profile: The Medical Research Council Cognitive Function and Ageing Study (CFAS)
Int. J. Epidemiol., October 1, 2006; 35(5): 1140 - 1145.
[Full Text] [PDF]